AMRX vs CAH
AMRX: Amneal Pharmaceuticals is a diversified biopharma company providing a broad range of essential, affordable generic and specialty medicines, alongside pharmaceutical distribution services. CAH: Cardinal Health is a healthcare services and logistics company that distributes pharmaceuticals, medical supplies, and healthcare IT solutions to pharmacies, hospitals, and health systems globally.
Side-by-side fundamentals
| Metric | AMRX | CAH | Edge |
|---|---|---|---|
| Price as of 2026-07-23 close | $17.97 | $225.98 | |
| Market cap as of 2026-07-24 | $5.7B | $52.4B | |
| P/E as of 2026-07-24 | 46.83 | 33.71 | CAH lower |
| PEG as of 2026-07-24 | 2.57 | 2.07 | CAH lower |
| Net margin as of 2026-07-24 | +4.0% | +0.6% | AMRX higher |
| Gross margin as of 2026-07-24 | +38.7% | +3.8% | AMRX higher |
| Operating margin as of 2026-07-24 | +14.3% | +0.9% | AMRX higher |
| ROE as of 2026-07-24 | -34.9% | +37.2% | CAH higher |
| ROA as of 2026-07-24 | +3.4% | +2.8% | AMRX higher |
| Debt / equity as of 2026-07-24 | 136.58 | 5.65 | CAH lower |
| Revenue growth (YoY) as of 2026-07-24 | +7.6% | +12.9% | CAH higher |
| Revenue CAGR (3y) SEC XBRL | +10.9% | +7.1% | AMRX higher |
| Dividend yield as of 2026-07-24 | n/a | +0.9% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-24 | 1.26 | 0.53 | |
| 1-year return as of 2026-07-23 close | +123.0% | +43.2% | AMRX higher |
Fundamentals: Finnhub, as of 2026-07-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-23.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.